Repurposing a cardiac test to help diagnose cardiac transthyretin amyloidosis
Featuring Dr. Frederick L. Ruberg, our senior cardiologist | Read more below https://www.cardiovascularbusiness.com/topics/imaging/resurrecting-tc-99m-pyp-cardiac-amyloidosis-therapies-emerge-old-test-gains-new
Proud to Present Dr. John Berk’s Research in hereditary ATTR Amyloidosis in New England Journal of Medicine
We are proud to announce 2 publications in the New England Journal of Medicine highlighting Dr. John Berk’s research in hereditary ATTR amyloidosis. You can find both articles linked below. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis NEJM | PubMed Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis NEJM | PubMed Congratulations to Dr. […]